01 Mar Coave Therapeutics
Posted at 15:53h
in
Rodolphe Clerval, CEO
April 15 | 3:00pm | Salone dei Cavalieri, Section 2
Paris, France
(Private)
Coave Therapeutics is a genetic medicine company pioneering the development of innovative solutions to enhance the precision, safety, efficacy and manufacturability of genetic medicines. With its proprietary ALIGATER™ platform, Coave is at the forefront of addressing challenges in gene therapy delivery to extra-hepatic tissues, creating a robust pipeline targeting CNS, neuromuscular and eye diseases.
